Top

Published in:

Open Access 01-12-2017 | Case Report

HPV-47-Induced and Tattoo-associated Verrucae Planae: Report of a Case and Review of the Literature

Authors: Nathalie Krecké, Sigrun Smola, Thomas Vogt, Cornelia Sigrid Lissi Müller

Published in: Dermatology and Therapy | Issue 4/2017

Abstract

The human papillomavirus (HPV), of which more than 200 different types have so far been identified, is an infectious disease impacting skin and mucous membranes. Several genera exist with distinct clinical impact. However, with ornamental tattoos increasing in popularity, a number of mostly cutaneous side effects have also been reported, such as infections, allergic reactions, or even a rise of malignant tumours within the tattoo. We report the first case of a β1-HPV-type infection in cutaneous lesions in terms of verrucae vulgares near a tattoo in an immunocompetent adult without pre-existing conditions, and discuss possible relationships and etiologic concerns of this association.

Iwasaki T, Sata T, Sugase M, Sato Y, Kurata T, Suzuki K, et al. Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti-HPV monoclonal antibody. J Pathol. 1992;168(3):293–300.CrossRefPubMed

Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70–9.CrossRefPubMedPubMedCentral

Bolatti EM, Chouhy D, Hosnjak L, Casal PE, Kocjan BJ, et al. Natural history of human papillomavirus infection of sun-exposed healthy skin of immunocompetent individuals over three climatic seasons and identification of HPV209, a novel betapapillomavirus. J Gen Virol. 2017;98(6):1334–48.CrossRefPubMed

Przybyszewska J, Zlotogorski A, Ramot Y. Re-evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate. J Am Acad Dermatol. 2017;76(6):1161–75.CrossRefPubMed

Cubie HA. Diseases associated with human papillomavirus infection. Virology. 2013;445(1–2):21–34.CrossRefPubMed

Handisurya A, Schellenbacher C, Kirnbauer R. Diseases caused by human papillomaviruses (HPV). J Dtsch Dermatol Ges. 2009;7(5):453–66 (quiz 66, 67).PubMed

Adachi A, Kiyono T, Hayashi Y, Ohashi M, Ishibashi M. Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs. J Clin Microbiol. 1996;34(2):369–75.PubMedPubMedCentral

Quint KD, Genders RE, de Koning MN, Borgogna C, Gariglio M, Bouwes Bavinck JN, et al. Human beta-papillomavirus infection and keratinocyte carcinomas. J Pathol. 2015;235(2):342–54.CrossRefPubMed

Smola S. Human papillomaviruses and skin cancer. Adv Exp Med Biol. 2014;810:192–207.PubMed

10.

Wang J, Aldabagh B, Yu J, Arron ST. Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol. 2014;70(4):621–9.CrossRefPubMedPubMedCentral

11.

Adachi A, Yasue H, Ohashi M, Ishibashi M. A novel type of human papilloma virus DNA from the lesion of epidermodysplasia verruciformis. Jpn J Cancer Res. 1986;77(10):978–84.PubMed

12.

Kiyono T, Adachi A, Ishibashi M. Genome organization and taxonomic position of human papillomavirus type 47 inferred from its DNA sequence. Virology. 1990;177(1):401–5.CrossRefPubMed

13.

Antonsson A. Review: antibodies to cutaneous human papillomaviruses. J Med Virol. 2012;84(5):814–22.CrossRefPubMed

14.

Stirn A, Brahler E, Hinz A. Prevalence, sociodemography, mental health and gender differences of tattooing and body piercing. Psychother Psychosom Med Psychol. 2006;56(11):445–9.CrossRefPubMed

15.

Cruz FA, Lage D, Frigerio RM, Zaniboni MC, Arruda LH. Reactions to the different pigments in tattoos: a report of two cases. An Bras Dermatol. 2010;85(5):708–11.CrossRefPubMed

16.

Kaur RR, Kirby W, Maibach H. Cutaneous allergic reactions to tattoo ink. J Cosmet Dermatol. 2009;8(4):295–300.CrossRefPubMed

17.

Kluger N, Cohen-Valensi R, Nezri M. Black lymph nodes—and a colourful skin. Lancet. 2008;371(9619):1214.CrossRefPubMed

18.

Mataix J, Silvestre JF. Cutaneous adverse reactions to tattoos and piercings. Actas Dermosifiliogr. 2009;100(8):643–56.CrossRefPubMed

19.

Oanta A, Irimie M. Tinea on a Tattoo. Acta Dermatovenerol Croat. 2016;24(3):223–4.PubMed

20.

Ramey K, Ibrahim J, Brodell RT. Verruca localization predominately in black tattoo ink: a retrospective case series. J Eur Acad Dermatol Venereol. 2016;30(10):34–6.CrossRef

21.

Kluger N. Viral warts and seborrhoeic keratoses on tattoos: a review of nine cases. J Eur Acad Dermatol Venereol. 2017;31(7):e340–42.

22.

Watkins DB. Viral disease in tattoos: verruca vulgaris. Arch Dermatol. 1961;84:306–9.CrossRefPubMed

23.

Young DF, Cole GW. The verrucous mermaid. Int J Dermatol. 1979;18:816–7.CrossRefPubMed

24.

Baxter SY, Deck DH. Tattoo-acquired verruca plana. Am Fam Physician. 1993;47:732.PubMed

25.

Miller DM, Brodell RT. Verruca restricted to the areas of black dye within a tattoo. Arch Dermatol. 1994;130:1453–4.CrossRefPubMed

26.

Ragland HP, Hubbel C, Stewart KR, et al. Verruca vulgaris inoculated during tattoo placement. Int J Dermatol. 1994;33:796–7.CrossRefPubMed

27.

Trefzer U, Schmollack KP, Stockfleth E, et al. Verrucae in multicolored decorative tattoo. J Am Acad Dermatol. 2004;50:478–9.CrossRefPubMed

28.

Saez M, Rodriguez-Martin M, Sidro-Sarto M, et al. Multiple verrucae vulgaris in a young woman’s tattoo. J Eur Acad Dermatol Venereol. 2006;20:356–7.CrossRefPubMed

29.

Jung JY, Shin HS, Won CH, Cho S. Facial verruca plana that developed after semipermanent tattooing. Ann Dermatol. 2009;21:92–4.CrossRefPubMedPubMedCentral

30.

Brajac I, Loncarek K, Stojnic-Sosa L, Gruber F. Delayed onset of warts over tattoo mark provoked by sunburn. J Eur Acad Dermatol Venereol. 2005;19(2):247–8.CrossRefPubMed

31.

Wanat KA, Tyring S, Rady P, Kovarik CL. Human papillomavirus type 27 associated with multiple verruca within a tattoo: report of a case and review of the literature. Int J Dermatol. 2014;53(7):882–4.CrossRefPubMed

32.

Favre M, Majewski S, Noszczyk B, Maienfisch F, Pura A, Orth G, et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol. 2000;114(3):403–7.CrossRefPubMed

33.

Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol. 1998;110(4):311–7.CrossRefPubMed

34.

Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol. 2002;138(5):649–54.CrossRefPubMed

35.

Köhler A, Forschner T, Meyer T, Ulrich C, Gottschling M, Stockfleth E, et al. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol. 2007;156:1078–80.CrossRefPubMed

36.

Plasmeijer EI, Neale RE, Buettner PG, de Koning MN, Ter Schegget J, Quint WG, et al. Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer. 2010;126:2614–21.PubMed

37.

Neale RE, Weissenborn S, Abeni D, Bavinck JN, Euvrard S, et al. Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22(4):719–27.CrossRefPubMed

38.

Akgul B, Lemme W, Garcia-Escudero R, Storey A, Pfister HJ. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol. 2005;150(1):145–51.CrossRefPubMed

39.

de Villiers EM, Ruhland A, Sekaric P. Human papillomaviruses in non-melanoma skin cancer. Semin Cancer Biol. 1999;9(6):413–22.CrossRefPubMed

40.

Ekstrom J, Muhr LS, Bzhalava D, Soderlund-Strand A, Hultin E, Nordin P, et al. Diversity of human papillomaviruses in skin lesions. Virology. 2013;447(1–2):300–11.CrossRefPubMed

41.

Korner R, Pfohler C, Vogt T, Muller CS. Histopathology of body art revisited—analysis and discussion of 19 cases. J Dtsch Dermatol Ges. 2013;11(11):1073–80.PubMed

42.

Shinohara MM, Nguyen J, Gardner J, Rosenbach M, Elenitsas R. The histopathologic spectrum of decorative tattoo complications. J Cutan Pathol. 2012;39(12):1110–8.CrossRefPubMed

43.

Nguyen HP, Doan HQ, Brunell DJ, Rady P, Tyring SK. Apoptotic gene expression in sinecatechins-treated external genital and perianal warts. Viral Immunol. 2014;27(10):556–8.CrossRefPubMed

44.

Scheinfeld N. Update on the treatment of genital warts. Dermatol Online J. 2013;19(6):18559.PubMed

Title: HPV-47-Induced and Tattoo-associated Verrucae Planae: Report of a Case and Review of the Literature
Authors: Nathalie Krecké
Sigrun Smola
Thomas Vogt
Cornelia Sigrid Lissi Müller
Publication date: 01-12-2017
Publisher: Springer Healthcare
Published in: Dermatology and Therapy / Issue 4/2017
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI: https://doi.org/10.1007/s13555-017-0197-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

HPV-47-Induced and Tattoo-associated Verrucae Planae: Report of a Case and Review of the Literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review

Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis

High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults

Erratum to: The Burden of Chronic Urticaria from Brazilian Patients’ Perspective

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page